Status | Study |
Recruiting |
Study Name: Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS) Condition: Dyskinesia, Medication-Induced Parkinson's Disease Date: 2016-01-14 Interventions: Device: tSMS Transcranial stat |
Terminated |
Study Name: Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease Condition: Idiopathic Parkinson's Disease Drug Induced Dyskinesia Date: 2013-02-07 Interventions: Drug: Topiramate Topiramate as |
Completed |
Study Name: Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias Condition: Parkinson Disease Dyskinesia, Drug-Induced Date: 2010-07-28 Interventions: Drug: AFQ056 |
Recruiting |
Study Name: Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia Condition: Dyskinesia, Drug-Induced Date: 2009-02-04 Interventions: Drug: aripiprazole Flexible dose: 5-30 mg/day Other |
Terminated |
Study Name: Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628) Condition: Akathisia, Drug-Induced Dyskinesia, Drug-Induced Date: 2008-05-27 Interventions: Drug: Preladenant capsules |
Completed |
Study Name: Movement Disorders Caused by Antipsychotic Drugs in Older Patients Condition: Dyskinesia, Drug-Induced Date: 2005-11-16 Interventions: Drug: Quetiapine Drug: Risperidone |
Completed |
Study Name: Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia Condition: Dyskinesia, Medication-induced Date: 2005-09-09 Interventions: Drug: Levetiracetam |
Recruiting |
Study Name: Botulinum Toxin for the Treatment of Involuntary Movement Disorders Condition: Chorea Drug Induced Dyskinesia Date: 1999-11-03 Interventions: Other: Botulinum Toxin |